middle.news
Why Did AFT Pharmaceuticals’ Profit Drop 23% Despite 6% Revenue Growth?
1:58am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Why Did AFT Pharmaceuticals’ Profit Drop 23% Despite 6% Revenue Growth?
1:58am on Monday 2nd of June, 2025 AEST
Key Points
Revenue rises 6% to NZ$208 million
Net profit declines 23% to NZ$12 million
Final dividend declared at NZ$0.016 per share
Net tangible assets per share increase to NZ$0.37
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Aft Pharmaceuticals (ASX:AFP)
OPEN ARTICLE